Bank of New York Mellon’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
|
|||||
|
2025
Q1 | $1.91M | Buy |
|
|||||
|
2024
Q4 | $2.37M | Sell |
|
|||||
|
2024
Q3 | $1.28M | Sell |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $1.22M | Sell |
|
|||||
|
2023
Q4 | $2.38M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Buy |
|
|||||
|
2023
Q2 | $2.09M | Buy |
|
|||||
|
2023
Q1 | $2.18M | Buy |
|
|||||
|
2022
Q4 | $2.3M | Buy |
|
|||||
|
2022
Q3 | $2.56M | Buy |
|
|||||
|
2022
Q2 | $2.18M | Sell |
|
|||||
|
2022
Q1 | $2.79M | Buy |
|
|||||
|
2021
Q4 | $3.91M | Buy |
|
|||||
|
2021
Q3 | $3.9M | Sell |
|
|||||
|
2021
Q2 | $5.97M | Buy |
|
|||||
|
2021
Q1 | $3.06M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Buy |
|
|||||
|
2020
Q3 | $745K | Buy |
|
|||||
|
2020
Q2 | $803K | Buy |
|
|||||
|
2020
Q1 | $505K | Buy |
|
|||||
|
2019
Q4 | $368K | Buy |
|
|||||
|
2019
Q3 | $423K | Buy |
|
|||||
|
2019
Q2 | $449K | Buy |
|
|||||
|
2019
Q1 | $89K | Sell |
|
|||||
|
2018
Q4 | $47K | Hold |
|
|||||
|
2018
Q3 | $82K | Sell |
|
|||||
|
2018
Q2 | $78K | Sell |
|
|||||
|
2018
Q1 | $337K | Sell |
|
|||||
|
2017
Q4 | $573K | Buy |
|
|||||
|
2017
Q3 | $459K | Sell |
|
|||||
|
2017
Q2 | $593K | Sell |
|
|||||
|
2017
Q1 | $642K | Buy |
|
|||||
|
2016
Q4 | $420K | Sell |
|
|||||
|
2016
Q3 | $425K | Sell |
|
|||||
|
2016
Q2 | $790K | Buy |
|
|||||
|
2016
Q1 | $268K | Buy |
|
|||||
|
2015
Q4 | $246K | Buy |
|